Health
AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’ | AstraZeneca
AstraZeneca has struck a $1bn (£773m) deal to buy a Belgian biotech company that specialises in cancer immunotherapies, the latest in a string of acquisitions
Read More